As per new notification by the Indian govt to amend New Drugs & Clinical Trials Rules 2019, a draft has been issued by the Ministry of Health and Family Welfare that suggests to add genetically modified DNA derived products as vaccines. These may contain allogeneic and autologous cells. These Cell-based human medicinal products may have genetically modified cells and cells that are associated with mesh, a scaffold and a device.
The New Drugs & Clinical Trials Rules 2019, rule 2, ...
